ProMIS Neurosciences, Inc. Share Price Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 50.2M 36.69M 2.94B |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.78M -2.23B | Net income 2025 * | -46M -33.63M -2.69B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.8
x | P/E ratio 2025 * |
-1.82
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.65% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 12/05/21 |
Neil Cashman
FOU | Founder | 72 | 22/01/04 |
Eugene Williams
CHM | Chairman | 64 | 28/06/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 07/03/14 |
Neil Cashman
FOU | Founder | 72 | 22/01/04 |
Neil Warma
CEO | Chief Executive Officer | 61 | 12/05/21 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |